la anakinra puede aportar un tratamiento prometedor para adultos con sı́ntomas refractarios? Nonetheless, the role of pharmacological agents such as anakinra warrants a further exploration. Future prospective investigations should be conducted in the subgroup of adult patients with recurrent pericarditis, which will help formulate standardized treatment strategies. We would greatly appreciate the authors ’ response and expert opinion
Pericarditis is the commonest form of pericardial disease. Unfortunately, despite optimal treatment,...
Pericarditis is the commonest form of pericardial disease. Unfortunately, despite optimal treatment,...
Introduction: Aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are first-lin...
Aims Accumulating evidence suggests idiopathic recurrent pericarditis as a disease of probable autoi...
SummaryIdiopathic recurrent pericarditis (IRP) impairs quality of life. Although its precise etiolog...
Non-steroidal anti-inflammatory drugs and colchicine are the cornerstone treatment for recurrent per...
Recurrent pericarditis is one of the most frequent pericardial diseases, affecting up to 30% of the ...
Pericarditis may recur in up to 30 % of adult patients, but recurrent pericarditis is a rare disease...
Aims: Novel therapies are needed for recurrent pericarditis, particularly when corticosteroid depend...
Recurrent pericarditis is a complication of acute pericarditis in 20–30% of the patients and is usua...
Interleukin 1 (IL-1) has been indicated as a mediator of recurrent pericarditis. Rilonacept, a solub...
Recurrent pericarditis is one of the most common and troublesome complications after an episode of p...
Introduction: Recurrent pericarditis (RP) is a possible complication of acute pericarditis (15–30%)...
Objective: Frequent flares of pericardial inflammation in recurrent or incessant pericarditis with c...
Idiopathic recurrent pericarditis (IRP) can be challenging to treat. Even after guideline-directed f...
Pericarditis is the commonest form of pericardial disease. Unfortunately, despite optimal treatment,...
Pericarditis is the commonest form of pericardial disease. Unfortunately, despite optimal treatment,...
Introduction: Aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are first-lin...
Aims Accumulating evidence suggests idiopathic recurrent pericarditis as a disease of probable autoi...
SummaryIdiopathic recurrent pericarditis (IRP) impairs quality of life. Although its precise etiolog...
Non-steroidal anti-inflammatory drugs and colchicine are the cornerstone treatment for recurrent per...
Recurrent pericarditis is one of the most frequent pericardial diseases, affecting up to 30% of the ...
Pericarditis may recur in up to 30 % of adult patients, but recurrent pericarditis is a rare disease...
Aims: Novel therapies are needed for recurrent pericarditis, particularly when corticosteroid depend...
Recurrent pericarditis is a complication of acute pericarditis in 20–30% of the patients and is usua...
Interleukin 1 (IL-1) has been indicated as a mediator of recurrent pericarditis. Rilonacept, a solub...
Recurrent pericarditis is one of the most common and troublesome complications after an episode of p...
Introduction: Recurrent pericarditis (RP) is a possible complication of acute pericarditis (15–30%)...
Objective: Frequent flares of pericardial inflammation in recurrent or incessant pericarditis with c...
Idiopathic recurrent pericarditis (IRP) can be challenging to treat. Even after guideline-directed f...
Pericarditis is the commonest form of pericardial disease. Unfortunately, despite optimal treatment,...
Pericarditis is the commonest form of pericardial disease. Unfortunately, despite optimal treatment,...
Introduction: Aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are first-lin...